Klotho Neurosciences Faces Delisting Concerns
Ticker: GRMLW · Form: 8-K · Filed: Oct 21, 2024 · CIK: 1907223
| Field | Detail |
|---|---|
| Company | Klotho Neurosciences, INC. (GRMLW) |
| Form Type | 8-K |
| Filed Date | Oct 21, 2024 |
| Risk Level | high |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $1 |
| Sentiment | bearish |
Sentiment: bearish
Topics: delisting, listing-standards, corporate-actions
Related Tickers: KLTO
TL;DR
Klotho Neurosciences might get delisted - big trouble for shareholders.
AI Summary
Klotho Neurosciences, Inc. filed an 8-K on October 21, 2024, reporting a notice of delisting or failure to satisfy continued listing rules as of October 14, 2024. The company, formerly known as ANEW Medical, Inc. and Redwoods Acquisition Corp., is incorporated in Delaware and has its principal business address in New York, NY.
Why It Matters
This filing indicates potential issues with Klotho Neurosciences' ability to remain listed on its exchange, which could significantly impact its stock liquidity and investor confidence.
Risk Assessment
Risk Level: high — A notice of delisting or failure to meet listing standards poses a significant risk to the company's continued trading and investor confidence.
Key Players & Entities
- Klotho Neurosciences, Inc. (company) — Registrant
- October 14, 2024 (date) — Earliest event reported
- October 21, 2024 (date) — Filing date
- ANEW Medical, Inc. (company) — Former company name
- Redwoods Acquisition Corp. (company) — Former company name
- 13576 Walnut Street (address) — Business address
FAQ
What specific listing rule or standard has Klotho Neurosciences failed to satisfy?
The filing does not specify the exact rule or standard that Klotho Neurosciences has failed to satisfy, only that a notice of delisting or failure to satisfy a continued listing rule or standard has been issued.
What is the date of the earliest event reported in this 8-K filing?
The date of the earliest event reported is October 14, 2024.
When was Klotho Neurosciences, Inc. previously known as?
Klotho Neurosciences, Inc. was formerly known as ANEW Medical, Inc. and prior to that, Redwoods Acquisition Corp.
What is the company's state of incorporation?
The company is incorporated in Delaware.
What is the primary business address of Klotho Neurosciences, Inc.?
The primary business address is 13576 Walnut Street, Suit.
Filing Stats: 504 words · 2 min read · ~2 pages · Grade level 12.5 · Accepted 2024-10-21 16:56:43
Key Financial Figures
- $1 — tock to maintain a minimum bid price of $1 per share for 30 consecutive business d
Filing Documents
- ea0218189-8k_klotho.htm (8-K) — 25KB
- 0001213900-24-089335.txt ( ) — 241KB
- klto-20241014.xsd (EX-101.SCH) — 3KB
- klto-20241014_def.xml (EX-101.DEF) — 26KB
- klto-20241014_lab.xml (EX-101.LAB) — 36KB
- klto-20241014_pre.xml (EX-101.PRE) — 25KB
- ea0218189-8k_klotho_htm.xml (XML) — 6KB
01. Notice of Delisting or Failure to Satisfy a Continued
Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On October 15, 2024, Klotho Neurosciences, Inc. (the "Company") received a delinquency notification letter (the "Notice") from the Nasdaq Stock Market LLC ("Nasdaq") due to the failure of the Company's common stock to maintain a minimum bid price of $1 per share for 30 consecutive business days as required by Nasdaq Listing Rule 5450(a)(1). In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has been provided 180 calendar days, or until April 14, 2025, to regain compliance. To regain compliance, prior to April 14, 2025, the closing bid price of the Company's common stock must be at least $1 for a minimum of ten consecutive business days. If the Company fails to timely regain compliance with Nasdaq Listing Rules, the Company's common stock will be subject to delisting from Nasdaq. 1
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: October 21, 2024 KLOTHO NEUROSCIENCES, INC. By: /s/ Joseph Sinkule Name: Joseph Sinkule Title: Chief Executive Officer 2